Delivery Order SPE2DB24D9803-SPE2DB25FJSEM

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $3,775.00, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The contract has an ultimate completion date of May 2, 2025 and was awarded on May 1, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,354.20, is for the delivery of 4,568,168,531 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, holding a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of NOVOLOG PENFILL 100 UNIT/ML 3ML, a pharmaceutical product, with a ceiling value of $2,338.00 and a performance period through May 22, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,017.60, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,063.40, is for the delivery of NovoLog 100 unit/mL FlexPen 3mL to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,020.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4563902919 NOVOLOG MIX 70-30 FLEXPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, contract number 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. The IDC enables DLA to issue delivery orders for a...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,004.99 under an indefinite delivery contract with the Defense Logistics Agency to supply Novolog 100 unit/ml Flexpen 3ml insulin injections. The delivery order is for fulfillment to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois, with performance to be completed by November 2, 2023. DMS Pharmaceutical Group holds additional delivery orders and an IDV through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products. The contract has a ceiling value of $2,902.03 and a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,436.52 contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The award has an ultimate completion date of May 1, 2025 and was made on April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The award has a potential value of $1,225.44 and a completion date of February 5, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to...
  • SPE2DB24D9803
    Indefinite Delivery Contract
  • SPE2DB24D9803-SPE2DB25FJSEM
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $2,265.00 and an ultimate completion date of May 22, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, and DMS Pharmaceutical Group Inc. has consistently secured contracts without specific set-aside designations, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets.

Generated 8/20/25, 9:59 AM